EFTA01754110

Sent: Th . From: Subject: the ctc microchip test To: jeffrey epstein <jeevacation©gmail.com> Hi Jeffrey, I'm helping a friend with stage 4 breast cancer-- she's about to take an inhibitor trial-- I'm contacting Harvard to see if she can get a CTC microchip test. Mass General are the leaders in this. It's not FDA approved. CTC microchip testing is the way to go and needs support. I thought you should look into it. I can send you the info if you are interested. Ctc microchip allows you to test the blood for circulating tumor cells. what's critical about it is that one can test for the entire pool of mutations in 'genetic real time': pre-inhibitor trial, during and post-- and one can get a sense of what type of mutations are either causing the resilience and/or driving tumor growth. instead of blindly applying inhibitors in sequence to one another-- the blood test allows one to apply a targeted cocktail inhibitor approach depending on the evolving pattern of mutations in the blood. ctc's are commonly used right now for counting cancer cell load-- but only the sparsely available micro-chip type can extract cancer cells and thus analyze them for mutation type. let me know what you think and I'll send you the info about the team at Mass General-- I think Sloan Kettering is experimenting with it too. Thanks cell: email: EFTA_R1_00054146 EFTA01754110